Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone
NCT00171288
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemia
Interventions
DRUG:
fluvastatin, ezetimibe
Sponsor
Novartis